Edition:
United States

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,026JPY
25 Sep 2017
Change (% chg)

-- (--)
Prev Close
¥2,026
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
169,445
52-wk High
¥2,124
52-wk Low
¥1,544

Latest Key Developments (Source: Significant Developments)

Zeria Pharmaceutical to repurchase 6.8 pct shares
Friday, 4 Aug 2017 03:22am EDT 

Aug 4 (Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it plans to repurchase up to 3.6 million shares, representing 6.8 percent of outstanding.Says share repurchase price at up to 7.2 billion yen in total.Says repurchase period from June 19 to Nov. 2.Previous news was disclosed on June 16.  Full Article

Zeria Pharmaceutical gets manufacture and marketing approval for Zentacort® Capsules 3mg
Wednesday, 28 Sep 2016 02:15am EDT 

Zeria Pharmaceutical Co Ltd <4559.T> :Says it gets manufacture and marketing approval for Zentacort® Capsules 3mg (Budesonide), as treatment for Crohn's disease.  Full Article

ZERIA PHARMACEUTICAL amends consolidated mid-year and full-year outlook for FY 2016
Wednesday, 28 Oct 2015 12:00am EDT 

ZERIA PHARMACEUTICAL CO LTD:Says the company lowered the consolidated mid-year outlook for revenue to 30,300 million yen from 31,000 million yen for FY ending March 2016.Operating profit forecast increased to 2,100 million yen from 1,600 million yen.Ordinary profit forecast increased to 1,550 million yen from 1,100 million yen.Net profit attributable to parent company's shareholders forecast increased to 1,600 million yen from 1,100 million yen.Earnings per share increased to 30.12 yen from 20.71 yen.Says the company reaffirmed the consolidated full-year outlook for revenue at 65,000 million yen for FY ending March 2016.Operating profit forecast increased to 4,500 million yen from 4,000 million yen.Ordinary profit forecast increased to 4,100 million yen from 3,500 million yen.Net profit attributable to parent company's shareholders forecast increased to 3,300 million yen from 3,000 million yen.Earnings per share increased to 62.13 yen from 56.48 yen.Comments the expected profit increase from Entocort is the main reason for the forecast.  Full Article

BRIEF-Zeria Pharmaceutical to repurchase 6.8 pct shares

* Says it plans to repurchase up to 3.6 million shares, representing 6.8 percent of outstanding